Related Experiment Video
Updated: Dec 26, 2025

Magnetic Adjustment of Afterload in Engineered Heart Tissues
Published on: May 5, 2020
Translating Translation to Mechanisms of Cardiac Hypertrophy
Michael J Zeitz1, James W Smyth1,2,3
1Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA 24016, USA.
Insights
Pathological cardiac hypertrophy, a hallmark of heart disease, involves altered protein synthesis. Understanding these translational changes and targeting pathways like mTOR may reveal new treatments for heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Translational Medicine
Background:
- Cardiac hypertrophy is a common response to chronic stress in heart disease.
- This hypertrophy elevates risks for arrhythmias and heart failure.
- Molecular mechanisms driving progression from hypertrophy to heart failure remain unclear.
Purpose of the Study:
- To review the role of translational regulation in pathological cardiac hypertrophy.
- To explore how altered protein synthesis contributes to disease progression.
- To discuss therapeutic targets for controlling translational output.
Main Methods:
- Review of recent studies on translational regulation in cardiac hypertrophy.
- Analysis of how global and transcript-selective protein synthesis is modulated.
- Examination of alternative translation modes in disease.
Main Results:
- Translational machinery is modulated during pathological cardiac hypertrophy.
- Enhanced global and transcript-selective protein synthesis occurs.
- Alternative translation modes contribute to the disease state.
Conclusions:
- Altered translational regulation is a key factor in pathological cardiac hypertrophy progression.
- Targeting the mTOR pathway and other emerging targets shows therapeutic potential.
- Further research into translational control mechanisms is crucial for developing heart failure treatments.
Abstract:
Cardiac hypertrophy in response to chronic pathological stress is a common feature occurring with many forms of heart disease. This pathological hypertrophic growth increases the risk for arrhythmias and subsequent heart failure. While several factors promoting cardiac hypertrophy are known, the molecular mechanisms governing the progression to heart failure are incompletely understood. Recent studies on altered translational regulation during pathological cardiac hypertrophy are contributing to our understanding of disease progression. In this brief review, we describe how the translational machinery is modulated for enhanced global and transcript selective protein synthesis, and how alternative modes of translation contribute to the disease state. Attempts at controlling translational output through targeting of mTOR and its regulatory components are detailed, as well as recently emerging targets for pre-clinical investigation.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Cardiac Performance
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

